The comparison of VHL-defective ccRCC and VHL-proficient pRCC tumors supports the role of ascorbate as a vital cofactor of dioxygenase enzymes that target HIF degradation via VHL. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.